Andere Sprachen Mayne Pharma Group Limited

Aktien

Markt geschlossen - Australian S.E. Andere Börsenplätze 08:10:14 28.06.2024			% 5 Tage	% 1. Jan.
4,71 ^AUD	+1,51 %		+2,17 %	-23,41 %

24.05.	Mayne Pharma bekräftigt H2 FY24 Ausblick in Folge der Cyberattacke auf Change Healthcare	MT
24.05.	Der Aktienrückkaufplan der Mayne Pharma Group Limited wird bis zum 29. November 2024 verlängert.	CI

Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland	03.06.
Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack	24.05.
Mayne Pharma Group Limited's Equity Buyback announced on May 10, 2023 has expired with 3,828,461 shares, representing 4.59% for AUD 17.16 million.	24.05.
Mayne Pharma Group Limited's Equity Buyback Plan Extended till November 29, 2024.	24.05.
Mayne Pharma Group Limited announces an Increase in Equity Buyback.	24.05.
Mithra announces grant of two additional U.S. patents for NEXTSTELLIS	13.05.
Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents	10.05.
Lagere omzet Mithra ondanks hogere productomzet	08.03.
Mithra zet zichzelf in de etalage	05.03.
MAYNE PHARMA REPORTS 1H FY24 RESULTS WITH A 43% INCREASE IN REVENUE TO A$188 MILLION AND $8 MILLION UNDERLYING EBITDA	27.02.
Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	26.02.
Tranche Update on Mayne Pharma Group Limited's Equity Buyback Plan announced on May 10, 2023.	25.02.
Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	25.02.
Brussel schudt tegenvallende inflatie data van zich af	17.02.
Mithra Pharmaceuticals Exits Stake in Mayne Pharma	16.02.
Brussel sluit in het groen	15.02.
Chemie en zorgvastgoed trekken de kop	15.02.
Kleine winsten in Brussel	15.02.
Brusselse beurs opent in het groen	15.02.
Mithra verkoopt Mayne Pharma	15.02.

Keine Ergebnisse zu dieser Suche